Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-24-129463

Chief R&D Officer sold 7,785 shares at $1.01 ($7,863)

From the SEC's structured data for this filing

Trades in this filing

Zalevsky Jonathan · Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-19 Sale : show line 1 in the form −7,785 $1.01 $7,863 243,019 D
Open-market sales · 7,785 sh · avg $1.01 · $7,863
Loading xslF345X05/ownership.xml…